Decipher cost per test
Ended Awarded Last action
- Contract number
- 36C24824N0350
- Awardee
-
Veracyte Labs SD Corporation UEI DKKCNLTYT2A1 Part of Veracyte, Inc.
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $184,714
Award facts
- Contract value 100% obligated
- $184,713.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$9,722 | |
| Original award | $194,435 |
About this award
Veracyte Labs SD Corporation, operating through its Decipher Biosciences division, received a Blanket Purchase Agreement (BPA) call award valued at $184,713.63 from Veterans Integrated Service Network 8 (VISN 8), a civilian agency within the Department of Veterans Affairs. This firm fixed-price contract, awarded February 1, 2024, with completion by January 31, 2025, represents a de-obligation of excess FY2024 funds under the parent BPA for cost-per-test Decipher genomic sequencing services. The contract was established without a set-aside designation under the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). Services will be performed in San Diego, California, where Veracyte Labs SD Corporation is headquartered.
The Decipher Prostate Cancer Test represents Veracyte's primary service offering to the VA and Defense Health Agency, analyzing tumor gene expression patterns to assess cancer risk, aggressiveness, and metastatic potential. This BPA call award enables VISN 8 facilities to continue accessing specialized genomic testing services for prostate cancer patients within the VA's precision medicine initiatives. Veracyte, Inc., the parent company headquartered in South San Francisco, has established an extensive federal contracting portfolio across multiple Veterans Integrated Service Networks and the Defense Health Agency, demonstrating established capability in delivering proprietary genomic diagnostic services to federal healthcare systems.
Quick answers
Who was awarded contract 36C24824N0350?
36C24824N0350 was awarded to Veracyte Labs SD Corporation by Veterans Integrated Service Network 8 (Veterans Health Administration) on February 1, 2024.
How much is contract 36C24824N0350 worth?
The government has obligated $184,714 on 36C24824N0350.
Is contract 36C24824N0350 an order under another contract?
Yes. 36C24824N0350 is a BPA call under 36F79721D0019-36C24823A0010, a blanket purchase agreement, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 36C24824N0350 competed?
The extent of competition for 36C24824N0350 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award